01.04.2014 - Swiss drug maker Novartis has ended a late-stage clinical trial of a chronic heart failure drug early, following strong interim results. The company said an independent committee...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)